Form 4 for IRD Opus Genetics, Inc.
Accepted 2023-12-05 00:00:00 ET · period of report 2023-12-01 · accession 0001140361-23-056374 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-12-05 | 2023-12-01 | IRD | Patel Ronil A. | Chief Business Off | A - Grant | $0.00 | +49.7K | 92.0K | +117% | $0 |
| D | 2023-12-05 | 2023-12-01 | IRD | Patel Ronil A. | Chief Business Off | A - Grant | $0.00 | +74.5K | 74.5K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-12-01 | A | A | 49,692 | $0.00 | 91,996 | D | — | — | (F1) Represents a grant of restricted stock units which vest with respect to 25% on the six month anniversary of the grant date, with the remaining shares vesting in equal installments every six months thereafter over the two years following the grant date, subject to continuing service. |
| 2 | Derivative | Employee Stock Option (right to buy) | 2023-12-01 | A | A | 74,538 | $0.00 | 74,538 | D | $2.99 · — to 2033-11-30 | 74,538 Common Stock | (F2) The option will vest with respect to 25% on the six month anniversary of the grant date, with the remaining shares vesting in equal installments every six months thereafter over the two years following the grant date, subject to continuing service. |